The USMIRC thrives on collaboration and partnerships with other institutions, organizations, and individuals to accelerate progress in myeloma research.
Academic Institutions
Collaborating with leading universities and research centers to leverage expertise and resources.
Pharmaceutical Companies
Partnering with industry to bring promising new drugs and treatments to patients.
Patient Advocacy Groups
Working closely with patient advocacy groups to ensure that patient needs are at the forefront of our research.
